Table 1.

Patient characteristics.

Patient number	27
Age (years, range)	30 (19-60)
Men/women	19/8
Total DLI number (range per patient)	55
One DLI vs. >1 (patients)	10 vs. 17
>1 DLI (range)	2-5
Donor
Matched related/parent	17 (63%)
Matched unrelated	10 (37%)
Conditioning regimen
Fludarabine with melphalan or cyclophosphamide +/- ATG*	25
Others	2
Patients who had a previous autograft	21 (75%)
No prior autograft	6 (25%)
Time to progression after autograft (months, range)	5 (1-21)
Time from disease progression after allotransplant to first DLI (months, range)	4 (1-34)
Concomitant chemotherapy**
Yes	10 (37%)
No	17 (63%)

DLI: Donor leukocyte infusion. ATG: Antithymocyte globulin.

^*For patients receiving a matched unrelated donor transplant.

^**Chemotherapy administered prior to at least one of the DLIs.